Opko Health Inc. (OPK) Receives Hold Rating from Oppenheimer Holdings Inc.
Opko Health Inc. (NYSE:OPK)‘s stock had its “hold” rating reiterated by investment analysts at Oppenheimer Holdings Inc. in a note issued to investors on Monday.
A number of other analysts also recently commented on the company. Jefferies Group restated a “hold” rating and issued a $10.00 target price on shares of Opko Health in a research note on Monday. JPMorgan Chase & Co. set a $14.00 target price on Opko Health and gave the stock a “buy” rating in a research note on Tuesday, August 9th. Zacks Investment Research upgraded Opko Health from a “sell” rating to a “hold” rating in a research note on Tuesday, July 12th. Standpoint Research upped their target price on Opko Health from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Tuesday, June 21st. Finally, Deutsche Bank AG lowered their target price on Opko Health from $11.00 to $10.00 and set a “hold” rating on the stock in a research note on Thursday, June 16th. Five equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $13.20.
Shares of Opko Health (NYSE:OPK) traded down 2.533% during mid-day trading on Monday, reaching $9.698. The company had a trading volume of 2,033,938 shares. The stock has a 50 day moving average of $10.07 and a 200-day moving average of $10.09. The company has a market capitalization of $5.34 billion and a price-to-earnings ratio of 40.577. Opko Health has a 52 week low of $7.12 and a 52 week high of $11.85.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/11/opko-health-inc-opk-receives-hold-rating-from-oppenheimer-holdings-inc.html
Opko Health (NYSE:OPK) last issued its earnings results on Monday, August 8th. The company reported $0.02 EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.05. The company earned $357.10 million during the quarter, compared to analysts’ expectations of $324.11 million. During the same quarter in the previous year, the company earned ($0.09) EPS. The firm’s quarterly revenue was up 742.2% compared to the same quarter last year. On average, analysts expect that Opko Health will post ($0.05) earnings per share for the current fiscal year.
In other news, CEO Phillip Md Et Al Frost bought 15,800 shares of the firm’s stock in a transaction dated Wednesday, July 13th. The shares were acquired at an average price of $9.65 per share, for a total transaction of $152,470.00. Following the completion of the transaction, the chief executive officer now directly owns 3,068,951 shares in the company, valued at approximately $29,615,377.15. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.
Several institutional investors have recently added to or reduced their stakes in the stock. Fisher Asset Management LLC increased its position in Opko Health by 1.1% in the third quarter. Fisher Asset Management LLC now owns 38,229 shares of the company’s stock valued at $405,000 after buying an additional 403 shares during the period. Williams Jones & Associates LLC increased its position in Opko Health by 352.0% in the second quarter. Williams Jones & Associates LLC now owns 11,300 shares of the company’s stock valued at $106,000 after buying an additional 8,800 shares during the period. IFP Advisors Inc increased its position in Opko Health by 72.5% in the second quarter. IFP Advisors Inc now owns 1,315,215 shares of the company’s stock valued at $12,284,000 after buying an additional 552,645 shares during the period. Public Employees Retirement System of Ohio increased its position in Opko Health by 11.9% in the second quarter. Public Employees Retirement System of Ohio now owns 113,894 shares of the company’s stock valued at $1,064,000 after buying an additional 12,075 shares during the period. Finally, Amalgamated Bank increased its position in Opko Health by 40.7% in the second quarter. Amalgamated Bank now owns 50,359 shares of the company’s stock valued at $506,000 after buying an additional 14,559 shares during the period.
Opko Health Company Profile
OPKO Health, Inc (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment primarily consists of its clinical laboratory operations.
Receive News & Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.